Journal article
Development of a novel CD4 TCR transgenic line that reveals a dominant role for CD8 dendritic cells and CD40 signaling in the generation of helper and CTL responses to blood-stage malaria
D Fernandez-Ruiz, LS Lau, N Ghazanfari, CM Jones, WY Ng, GM Davey, D Berthold, L Holz, Y Kato, MH Enders, G Bayarsaikhan, SH Hendriks, LIM Lansink, JA Engel, MSF Soon, KR James, A Cozijnsen, V Mollard, AD Uboldi, CJ Tonkin Show all
Journal of Immunology | AMER ASSOC IMMUNOLOGISTS | Published : 2017
Abstract
We describe an MHC class II (I-Ab)-restricted TCR transgenic mouse line that produces CD4+ T cells specific for Plasmodium species. This line, termed PbT-II, was derived from a CD4+ T cell hybridoma generated to blood-stage Plasmodium berghei ANKA (PbA). PbT-II cells responded to all Plasmodium species and stages tested so far, including rodent (PbA, P. berghei NK65, Plasmodium chabaudi AS, and Plasmodium yoelii 17XNL) and human (Plasmodium falciparum) blood-stage parasites as well as irradiated PbA sporozoites. PbT-II cells can provide help for generation of Ab to P. chabaudi infection and can control this otherwise lethal infection in CD40L-deficient mice. PbT-II cells can also provide hel..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council of Australia and the Australian Research Council.